177 Lu-octreotate therapy for neuroendocrine tumours is enhanced by Hsp90 inhibition
Journal article, 2019

Show more

neuroendocrine tumours

Lu-177-octreotate therapy

peptide receptor radionuclide therapy

ganetespib

Hsp90 inhibitor

Show all persons

Published in

Endocrine-Related Cancer

1351-0088 (ISSN) 14796821 (eISSN)

Vol. 26 Issue 4 p. 437-449

Categorizing

Subject Categories (SSIF 2011)

Hematology

Urology and Nephrology

Cancer and Oncology

Identifiers

DOI

10.1530/ERC-18-0509

PubMed

30730850

More information

Latest update

6/22/2021